Author:
Khan Muhammad Shahzeb,Greene Stephen J.,DeVore Adam D.
Reference5 articles.
1. Effect of natriuretic peptide-guided therapy on hospitalization or cardiovascular mortality in high-risk patients with heart failure and reduced ejection fraction: a randomized clinical trial;Felker;JAMA,2017
2. Prognostic impact of repeated NT-proBNP measurements in patients with heart failure with reduced ejection fraction;Fuery;J Am Coll Cardiol HF,2024
3. Clinical profile and prognostic significance of natriuretic peptide trajectory following hospitalization for worsening chronic heart failure: findings from the ASTRONAUT trial;Greene;Eur J Heart Fail,2015
4. Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial;Mebazaa;Lancet,2022
5. Associations between New York Heart Association classification, objective measures, and long-term prognosis in mild heart failure: a secondary analysis of the PARADIGM-HF trial;Rohde;JAMA Cardiol,2023
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献